dehydroabietic acid has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fu, Y; Gao, G; Hölscher, C; Li, E; Song, J; Wang, H; Wang, P; Xie, Z; Xu, J; Yuan, Y; Zeng, H; Zhang, Z | 1 |
| Aoyagi, Y; Hitotsuyanagi, Y; Ichimaru, Y; Mizuno, Y; Nonogaki, T; Takeya, K; Yamaguchi, T; Yoshioka, H | 1 |
2 other study(ies) available for dehydroabietic acid and Liver Steatosis
| Article | Year |
|---|---|
Dehydroabietic acid alleviates high fat diet-induced insulin resistance and hepatic steatosis through dual activation of PPAR-γ and PPAR-α.
Topics: 3T3-L1 Cells; Abietanes; Animals; Cell Line; Diet, High-Fat; Fatty Liver; Humans; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mitochondria; Oxygen Consumption; PPAR alpha; PPAR gamma | 2020 |
Methyl dehydroabietate counters high fat diet-induced insulin resistance and hepatic steatosis by modulating peroxisome proliferator-activated receptor signaling in mice.
Topics: 3T3-L1 Cells; Abietanes; Adipocytes; Adipogenesis; Animals; Body Weight; Diet, High-Fat; Fatty Liver; Hypertrophy; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Organ Size; PPAR gamma; Signal Transduction | 2018 |